Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 11/02/2025 7:48:26 PM
Board Marks: 394
Posts Today: 5
Board Views Today: 25690
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
mountaineer
07/08/2025 5:50:34 PM
Yes the following is AI generated, but
(8)
brentie
07/08/2025 4:16:26 PM
"Finally, the Leronlimab, Ulocuplumab,
(24)
Camp2800
07/08/2025 12:28:00 PM
When you add up all of the tea leaves
(11)
Riztheinvestor
07/08/2025 10:25:20 AM
When the FDA completely lost oversight
(7)
grow
07/08/2025 10:24:32 AM
Yes I agree. Not seeing the ESMO CRC
(3)
Respert24
07/08/2025 10:15:34 AM
Exactly. You'd hope everyone involved
(13)
Riztheinvestor
07/08/2025 10:12:45 AM
Great pasta metaphor. But some of us
(3)
Jake2212
07/08/2025 10:03:46 AM
Respert: And when the FDA stopped LL
(12)
Riztheinvestor
07/08/2025 10:00:14 AM
This is very interesting. Havent
(8)
mountaineer
07/08/2025 9:30:46 AM
Good job! Only 376 words
(8)
Respert24
07/08/2025 8:55:40 AM
Your questions simple enough without
(27)
MGK_2
07/08/2025 7:10:13 AM
I didn't get any responses, so I put
(8)
ohm20
07/08/2025 12:50:27 AM
So I turned to our " friend" A I for
(9)
Shelly2626
07/07/2025 11:48:08 PM
Been here , but in CYDY SINCE
(5)
brentie
07/07/2025 10:43:59 PM
Leronlimab Shows Encouraging Survival
(10)
brentie
07/07/2025 10:28:32 PM
New Trials Target Brain, Bladder,
(7)
My69z
07/07/2025 8:37:28 PM
The FDA ..HAS approved LL @ 700mg CRC
(7)
MidnightRider
07/07/2025 8:07:57 PM
It's obvious I have been struggling
(9)
Mr3Putt
07/07/2025 6:21:49 PM
FWIW on July 9 it'll be the one year
(5)
Shelly2626
07/07/2025 6:18:55 PM
GLTA Longs..... I'm extremely
(10)
chazzledazzle
07/07/2025 5:52:26 PM
Short term newsmakers are Company
(6)
ohm20
07/07/2025 5:50:56 PM
Short version: if a company licenses
(9)
Riztheinvestor
07/07/2025 5:47:18 PM
If I had to guess, and Im not
(17)
KenChowder
07/07/2025 5:18:10 PM
Yes, up nearly 12% on the day --
(6)
hoops
07/07/2025 3:48:32 PM
In the meantime CYDY is quietly up 12%
(4)
nelsonsjavaheads
07/07/2025 3:23:32 PM
Just RELAX. This is a board that we are
(16)
My69z
07/07/2025 2:48:42 PM
Like i said....he was talking 2 someone
cardamine
07/07/2025 2:44:46 PM
poster display session in Hall B0 on
Evil Rabbit
07/07/2025 2:44:31 PM
Because he said he had you on ignore??
(9)
Evil Rabbit
07/07/2025 2:41:27 PM
Language like that will get you blanket
(4)
HouseofCards
07/07/2025 1:27:13 PM
I would expect updates on any or all of
(4)
KenChowder
07/07/2025 12:43:08 PM
Short version: if a company licenses
(1)
Cycl2R
07/07/2025 11:32:45 AM
Jake wrote re LL TNBC conclusive trial:
(3)
MidnightRider
07/07/2025 11:08:42 AM
Can someone please offer an opinion
(1)
Respert24
07/07/2025 10:51:39 AM
I cant see the business model
(21)
Mr3Putt
07/07/2025 10:31:49 AM
Not a pharma rep nor exec so I have no
Evil Rabbit
07/07/2025 10:30:37 AM
The five-year anniversary of our RTF
(14)
My69z
07/07/2025 10:25:16 AM
Or, what do you think about ICI's
My69z
07/07/2025 10:12:07 AM
Cytodyn's not for sale ---- for yrs
(1)
Mr3Putt
07/07/2025 10:05:14 AM
Paying Cytodyn dosen't get them ICI
My69z
07/07/2025 9:59:29 AM
Partnering directly with us, dosen't
(1)
Mr3Putt
07/07/2025 9:46:29 AM
If LL makes all ICI's better, why
(4)
My69z
07/07/2025 9:43:12 AM
Cytodyn should buy the CTC test
My69z
07/07/2025 9:37:44 AM
Why would an ICI mfgr spend let's say
Mr3Putt
07/07/2025 7:22:13 AM
IIRC by July 2nd of this month.
hoops
07/07/2025 5:14:23 AM
Is the $2M payment from Amarex due this
(1)
My69z
07/07/2025 3:27:00 AM
December 7, 2022 R&D Update: Pg. 98
(1)
Jake2212
07/06/2025 10:18:36 PM
Based on logic and common sense, the
(33)
MGK_2
07/06/2025 8:43:11 PM
To Any/All who feel like answering:
(1)
MJS719
07/06/2025 4:25:07 PM
I believe we are waiting for some new
(16)
Newer
Older
Recent Articles
Trump's Tariffs Controversy: Why He Stays Away from Court
Savara Inc. Legal Update: What Investors Need to Know
V.F. Corporation Investors Should Be Aware of Class Action
Engwe Unveils Advanced E-Bikes at Major Milan Event
Trump's Unique Views on Cryptocurrency and His Family's Role
Concluding Highlights of the Financial Street Forum 2025 Events
Stock Market Update: Nasdaq Climbs as Earnings Surprise Investors
Stocks to Keep an Eye on This Monday: Key Updates & Insights
Trump's Stance on Nvidia's Blackwell AI Chip and Its Future
2025 Gold Glove Award Winners Announced: Defensive Excellence
Faraday Future Welcomes Chris Nixon Cox as Strategic Advisor
Tronox Holdings Investors Urged to Take Action Before Deadline
How the Surge in AI Usage is Impacting Our Energy Bills
Cryptocurrency Market Update: Key Insights on BTC, ETH, and More
Aquilius Achieves Record-Breaking Fundraising Success
GFM Services Berhad Earns Leadership Recognition for Innovation
AgiBot Pioneers Reinforcement Learning in Robotics Deployment
Aquilius Secures $1.1 Billion for Asia Pacific Real Estate Fund
AgiBot Unveils Milestone in Reinforcement Learning Robotics
Aquilius Secures Unprecedented $1.1 Billion for Real Estate Growth
Exploring the Renaissance of Baijiu: A Global Affair
Nota AI's KOSDAQ Listing Marks a New Era for AI Innovations
Faraday Future Expands Operations with Strategic Partnerships
Bitget and Fasanara Capital Unite for Enhanced Digital Asset Liquidity
WPP plc Investors Urged to Act Before Class Action Deadline
HUTCHMED Showcases Innovative Cancer Treatments at Recent Event
Benitec Biopharma's Latest Update: Advancing Gene Therapy Research
Benitec Biopharma Updates Phase 1b/2a Study for OPMD
HUTCHMED Advances Innovative Cancer Treatments and Pipeline
Join the Movement: Stand Up Against Fraud with Rosen Law
SAMURAI Paint Unveils Innovative Car Spray Paint Series
FireFly Welcomes New Non-Executive Director with Vast Industry Expertise
Dave Ramsey's Critique of Congressional Incompetence
Critical Insights on Savara Inc. and the Upcoming Class Action
FireFly Metals Welcomes Experienced Director to the Team
Discovering Innovations in Vascular Treatments from The VEINS 2025
Lantheus Holdings Class Action: What Investors Need to Know
Unveiling America's Tech Revolution: Buck Sexton's Insights
Alvotech Faces Challenges in Biologics License Approval Process
Alvotech's Progress on FDA Review for AVT05 Biosimilar
Secure Your Rights: Join the Avantor, Inc. Class Action
Latest Updates on Caribou Biosciences' CAR-T Cell Trials
How Tanka's AI Platform is Shaping the Future of Startups
Caribou Biosciences Announces Upcoming Webcast for CAR-T Data
Kevin O'Leary's Journey: Overcoming Failures to Find Freedom
The Secrets Behind A $6.5 Million Used Clothing Business Success
Important Legal Update for Tronox Investors: Act Now
Class Action Alert: Quantum Corporation Stockholder News
Warren Buffett's Reflective Lessons from Investment Mistakes
Transforming Housekeeping into a Lucrative Career Path